Project Number 3R01AG061091-04S1 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for A Phase 3 Pivotal Trial of AGB101 to Slow Progression in MCI due to Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 8. Late-stage Clinical Drug Development (Phase II/III and III Clinical Trials) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator MOHS, RICHARD CHARLES Principal Investigator First Name RICHARD CHARLES Principal Investigator Last Name MOHS Awardee Organization AGENEBIO, INC. Awardee State Maryland Contact PI Country United States Project Detail Funding Opportunity Announcement PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) FY Overall Cost $1,595,216 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
